Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Baxter
US Army
US Department of Justice
Federal Trade Commission
Colorcon
Novartis
McKesson
Johnson and Johnson
Cerilliant

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018766

« Back to Dashboard

NDA 018766 describes ANSAID, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the ANSAID profile page.

The generic ingredient in ANSAID is flurbiprofen. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the flurbiprofen profile page.
Summary for 018766
Tradename:ANSAID
Applicant:Pharmacia And Upjohn
Ingredient:flurbiprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018766

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Oct 31, 1988TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Oct 31, 1988TE:RLD:No

Expired US Patents for NDA 018766

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-002 Oct 31, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-003 Oct 31, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-002 Oct 31, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-003 Oct 31, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Baxter
UBS
Cantor Fitzgerald
Dow
Queensland Health
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot